AccurEdit Therapeutics Raises $75 M Series A, Secures Strategic Partners for Gene‑Editing Platform
CompanyDeals

AccurEdit Therapeutics Raises $75 M Series A, Secures Strategic Partners for Gene‑Editing Platform

Changchun GeneScience Secures China Approval for Long‑Acting FSH‑CTP Injection
CompanyDrug

Changchun GeneScience Secures China Approval for Long‑Acting FSH‑CTP Injection

Ipsen Launches BYLVAY in China for Rare Liver Disease
CompanyDrug

Ipsen Launches BYLVAY in China for Rare Liver Disease

TJ Biopharma Secures Series C2 Funding to Accelerate Autoimmune and Oncology Pipeline
CompanyDeals

TJ Biopharma Secures Series C2 Funding to Accelerate Autoimmune and Oncology Pipeline

Full‑Life Technologies Raises $77 M in Series C and Debt Funding
CompanyDeals

Full‑Life Technologies Raises $77 M in Series C and Debt Funding

GSK Names Luke Miels as CEO to Drive Growth
Company

GSK Names Luke Miels as CEO to Drive Growth

Simnova Secures FDA IND for CAR‑NK Therapy in SLE
CompanyDrug

Simnova Secures FDA IND for CAR‑NK Therapy in SLE

Sinopharm Secures NMPA Approval for QuadrivalentHPV Vaccine
CompanyDrug

Sinopharm Secures NMPA Approval for QuadrivalentHPV Vaccine

Hua Medicine Secures Hong Kong NDA Acceptance for Dorzagliatin, First‑In‑Class Glucokinase Activator
CompanyDrug

Hua Medicine Secures Hong Kong NDA Acceptance for Dorzagliatin, First‑In‑Class Glucokinase Activator

Xinhua Pharma Wins China Trial Approval for Dual‑Mechanism PAH Drug LXH‑1211
CompanyDrug

Xinhua Pharma Wins China Trial Approval for Dual‑Mechanism PAH Drug LXH‑1211

Simcere Secures FDA Approval for ADC SIM0609 in Advanced Solid Tumors
CompanyDrug

Simcere Secures FDA Approval for ADC SIM0609 in Advanced Solid Tumors

CMS Wins NMPA Green Light for Phase‑3 Trial of MG‑K10 Anti‑IL‑4Rα in Chronic Urticaria
CompanyDrug

CMS Wins NMPA Green Light for Phase‑3 Trial of MG‑K10 Anti‑IL‑4Rα in Chronic Urticaria